Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2314880835', 'doi': 'https://doi.org/10.4172/2153-2435.s1.011', 'title': 'Advances in nano drugs for cancer chemotherapy: Biopharmaceutical trends and perspectives and case studies', 'display_name': 'Advances in nano drugs for cancer chemotherapy: Biopharmaceutical trends and perspectives and case studies', 'publication_year': 2013, 'publication_date': '2013-01-01', 'ids': {'openalex': 'https://openalex.org/W2314880835', 'doi': 'https://doi.org/10.4172/2153-2435.s1.011', 'mag': '2314880835'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.4172/2153-2435.s1.011', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764521035', 'display_name': 'Pharmaceutica Analytica Acta', 'issn_l': '2153-2435', 'issn': ['2153-2435'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320466', 'host_organization_name': 'OMICS Publishing Group', 'host_organization_lineage': ['https://openalex.org/P4310320466'], 'host_organization_lineage_names': ['OMICS Publishing Group'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081027897', 'display_name': 'Panayiotis P. Constantinides', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Panayiotis P Constantinides', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5081027897'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '04', 'issue': '02', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10063', 'display_name': 'Nanoparticle-Based Drug Delivery Systems', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2502', 'display_name': 'Biomaterials'}, 'field': {'id': 'https://openalex.org/fields/25', 'display_name': 'Materials Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10063', 'display_name': 'Nanoparticle-Based Drug Delivery Systems', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2502', 'display_name': 'Biomaterials'}, 'field': {'id': 'https://openalex.org/fields/25', 'display_name': 'Materials Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T12627', 'display_name': 'Biomedical Applications of Graphene Nanomaterials', 'score': 0.9806, 'subfield': {'id': 'https://openalex.org/subfields/2204', 'display_name': 'Biomedical Engineering'}, 'field': {'id': 'https://openalex.org/fields/22', 'display_name': 'Engineering'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10725', 'display_name': 'Mechanisms and Applications of RNA Interference', 'score': 0.9506, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/biopharmaceutical', 'display_name': 'Biopharmaceutical', 'score': 0.80103636}, {'id': 'https://openalex.org/keywords/cancer-chemotherapy', 'display_name': 'Cancer chemotherapy', 'score': 0.5777236}, {'id': 'https://openalex.org/keywords/cancer-drugs', 'display_name': 'Cancer drugs', 'score': 0.56446874}, {'id': 'https://openalex.org/keywords/biomedical-applications', 'display_name': 'Biomedical Applications', 'score': 0.541921}, {'id': 'https://openalex.org/keywords/cancer-therapy', 'display_name': 'Cancer Therapy', 'score': 0.537673}, {'id': 'https://openalex.org/keywords/sirna-therapeutics', 'display_name': 'siRNA Therapeutics', 'score': 0.529857}, {'id': 'https://openalex.org/keywords/tumor-targeting', 'display_name': 'Tumor Targeting', 'score': 0.528167}, {'id': 'https://openalex.org/keywords/nanocarriers', 'display_name': 'Nanocarriers', 'score': 0.521633}], 'concepts': [{'id': 'https://openalex.org/C2781047461', 'wikidata': 'https://www.wikidata.org/wiki/Q679692', 'display_name': 'Biopharmaceutical', 'level': 2, 'score': 0.80103636}, {'id': 'https://openalex.org/C2983288658', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Cancer chemotherapy', 'level': 3, 'score': 0.5777236}, {'id': 'https://openalex.org/C3020340455', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Cancer drugs', 'level': 3, 'score': 0.56446874}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5343743}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.45129982}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.44971877}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42749077}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26047856}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.14252129}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.12949523}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.4172/2153-2435.s1.011', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764521035', 'display_name': 'Pharmaceutica Analytica Acta', 'issn_l': '2153-2435', 'issn': ['2153-2435'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320466', 'host_organization_name': 'OMICS Publishing Group', 'host_organization_lineage': ['https://openalex.org/P4310320466'], 'host_organization_lineage_names': ['OMICS Publishing Group'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4250104310', 'https://openalex.org/W4235286999', 'https://openalex.org/W3186279510', 'https://openalex.org/W2597027489', 'https://openalex.org/W2581834833', 'https://openalex.org/W2413405428', 'https://openalex.org/W2413138590', 'https://openalex.org/W2294527235', 'https://openalex.org/W2016389161', 'https://openalex.org/W156760605'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2314880835', 'counts_by_year': [], 'updated_date': '2024-09-18T02:33:08.505547', 'created_date': '2016-06-24'}